Cover Image

Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma

Saved in:

Bibliographic Details
Main Authors:	Zhipeng Li (Author), Huaxin Zhou (Author), Zhijia Xia (Author), Tong Xia (Author), Gang Du (Author), Strohmer Dorothee Franziska (Author), Xiaoming Li (Author), Xiangyu Zhai (Author), Bin Jin (Author)
Format:	Book
Published:	BMC, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2023)

Intrahepatic cholangiocarcinoma after the Fontan procedure
by: Yuichi Shibui, et al.
Published: (2019)

Targeting PI3K/mTOR signaling in cancer
by: Alexandre Arcaro
Published: (2014)

Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway
by: Xiangjin Zheng, et al.
Published: (2021)

Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
by: Mina Komuta
Published: (2024)

Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma
by: Mayur Parkhi, et al.
Published: (2023)

Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity
by: Gigin Lin, et al.
Published: (2018)

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
by: Xianbo Wu, et al.
Published: (2022)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
by: Jieun Bang, et al.
Published: (2023)

RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
by: Zhun Wei, et al.
Published: (2023)

Along for the Ride: Intrahepatic Cholangiocarcinoma with Concomitant LECT2 Amyloidosis
by: Phoenix D. Bell, et al.
Published: (2020)

Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway
by: Yue Wang, et al.
Published: (2019)

Mitochondrial toxicants in Xian-Ling-Gu-Bao induce liver injury by regulating the PI3K/mTOR signaling pathway: an in vitro study
by: Shujuan Piao, et al.
Published: (2022)

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
by: Somayyeh Ghareghomi, et al.
Published: (2023)

Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes
by: Marwa El-Sheikh, et al.
Published: (2023)

The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
by: Amin Iranpanah, et al.
Published: (2023)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021)

Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
by: Yanxin Sun, et al.
Published: (2024)

Presentation of Intrahepatic Cholangiocarcinoma with Fulminant Hepatic Failure: A Case Report
by: Thara Pratap, et al.
Published: (2019)

Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity via PI3K/Akt/mTOR Pathway
by: Xinran Xie, et al.
Published: (2021)

Sodium cantharidate promotes autophagy in breast cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway
by: Jin-Long Pang, et al.
Published: (2022)

Burn Ointment Promotes Cutaneous Wound Healing by Modulating the PI3K/AKT/mTOR Signaling Pathway
by: Dali Gan, et al.
Published: (2021)

Design, Synthesis, and Biological Evaluation of Sulfonamide Methoxypyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors
by: Haotian Gao, et al.
Published: (2023)

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
by: Lulu Xie, et al.
Published: (2022)

Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
by: Chao Dong, et al.
Published: (2021)

Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic
by: Aglaia Skolariki, et al.
Published: (2022)

PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren's Syndrome
by: Ping Zeng, et al.
Published: (2022)

Untargeted UPLC-MS-based metabolomics analysis reveals the metabolic profile of intrahepatic cholangiocarcinoma process and the intervention effect of Osthole in mice
by: Xin Chen, et al.
Published: (2022)

mTOR in Human Diseases
by: Dormond, Olivier
Published: (2019)

NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways
by: Bihui Li, et al.
Published: (2022)

Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway
by: Xiaoyi Qi, et al.
Published: (2023)

Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway
by: Zhao KH, et al.
Published: (2017)

Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes
by: Zheng X, et al.
Published: (2019)

The New PI3K/mTOR Inhibitor GNE-477 Inhibits the Malignant Behavior of Human Glioblastoma Cells
by: Yixuan Wang, et al.
Published: (2021)

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis
by: Cindy Neuzillet, et al.
Published: (2022)

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration
by: Lavinia Patricia Mocan, et al.
Published: (2024)

Biocompatible Snowman-like Dimer Nanoparticles for Improved Cellular Uptake in Intrahepatic Cholangiocarcinoma
by: Ruyin Chen, et al.
Published: (2023)

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
by: Sheng Hu, et al.
Published: (2022)

Intrahepatic cholangiocarcinoma developing seven years after resection of congenital biliary dilatation
by: Kanako Omata, et al.
Published: (2020)

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
by: Zhenyu Zhang, et al.
Published: (2018)